ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

Exercise May Help Combat Leukemia Patients’ Fatigue

August 28, 2009

Simone Replaces Levine As Cancer Policy Board Chairman

April 19, 2002

DCT To Announce June 1 Guidelines For CREG Program In Cell Kinetics Related To Chemo, Radiotherapy

April 25, 1975

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013